Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors
- 1 March 1989
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 34 (S3) , S28-S39
- https://doi.org/10.1007/bf01536043
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- REGRESSION OF LIVER METASTASES IN PATIENT WITH GASTRIN-SECRETING TUMOUR TREATED WITH SMS 201-995The Lancet, 1986
- Cushing's Syndrome in Patients with the Zollinger–Ellison SyndromeNew England Journal of Medicine, 1986
- Treatment of Inoperable Glucagonoma with the Long-Acting Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1986
- Effect of a Long-Acting Somatostatin Analogue (SMS 201–995) in a Patient with Pancreatic CholeraNew England Journal of Medicine, 1985
- SomatostatinNew England Journal of Medicine, 1983
- Production of Secretory Diarrhea by Intravenous Infusion of Vasoactive Intestinal PolypeptideNew England Journal of Medicine, 1983
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic choleraDigestive Diseases and Sciences, 1982
- Tumors of the Endocrine PancreasNew England Journal of Medicine, 1982
- Somatostatinoma SyndromeNew England Journal of Medicine, 1979